Document Detail


Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
MedLine Citation:
PMID:  20844465     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are rare but severe cutaneous adverse reactions related to a variety of medications. Although rare, SJS and TEN have a significant impact on public health because of high mortality. Also, if the SJS/TEN physiopathology is still unclear, a specific immune response to one or more drugs is involved, constituting a form of delayed-type hypersensitivity. Patients with SJS/TEN are often critically ill; therefore, they must be admitted to hospitals capable of delivering critical care. Currently, no treatment modality has been established as standard for these patients; therefore, therapy is primarily supportive and symptomatic and involves a multidisciplinary approach.
Authors:
Alfredo Tartarone; Rosa Lerose
Related Documents :
17363955 - Soluble fas ligand: is it a critical mediator of toxic epidermal necrolysis and stevens...
1603915 - Spanish toxic oil syndrome: ten years after the disaster.
21382725 - Endoscopic successful management of tracheobronchomalacia with laser: apropos of a moun...
15651515 - Toxic epidermal necrolysis syndrome--management and case report.
3591835 - Median cleft of the upper lip associated with lipomas of the central nervous system and...
18559755 - Distal intestinal obstructive syndrome in adults with cystic fibrosis: a surgical persp...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Therapeutic drug monitoring     Volume:  32     ISSN:  1536-3694     ISO Abbreviation:  Ther Drug Monit     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7909660     Medline TA:  Ther Drug Monit     Country:  United States    
Other Details:
Languages:  eng     Pagination:  669-72     Citation Subset:  IM    
Affiliation:
Division of Oncology, Centro di Riferimento Oncologico della Basilicata, IRCCS Rionero in Vulture, PZ, Italy. tarta1@virgilio.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assays for measuring rivaroxaban: their suitability and limitations.
Next Document:  A novel role of innate immune responses (toll-like receptor-4) in triggering graft-versus-host disea...